Latest News｜Institute for Biotechnology and Medicine Industry│IBMI

Latest News

Date	Subject	Media
2025-12-13	Lin BioScience’s Belite Gains UK Approval to Submit Conditional Marketing Authorization Based on Interim Analysis Results	Investor
2025-12-13	AI-Assisted Precision Triage Supports Emergency Department Flow, Ministry of Health Pushes for Integrated Health Data	United Daily News (Taiwan)
2025-12-13	Acer Subsidiary Altos Partners with Repurgenesis to Build High-Performance AI Drug Development Platform	MoneyDJ
2025-12-13	TAHO Pharmaceuticals’ TAH3311 Officially Submits European Drug Application, First Orally Dissolvable Apixaban Film Targets Global Anticoagulant Market	Commercial Times
2025-12-13	Fubon-Backed StemCyte Aims for IPO, First Foreign Company Filing for Taiwan Listing This Year	Economic Daily News
2025-12-13	Mobisnet Technology: From Tax Systems to Smart Hospitals, 100% Taiwanese Robots Go Global	IBMI
2025-12-13	Anxo Pharmaceutical Licenses ADHD Drug to South Korea’s WhanIn Pharm to Capture $60 Million Market Opportunity	Economic Daily News
2025-12-13	AnHorn Medicines’ AI-Designed Drug AH-001 Completes U.S. Phase I Trial, Demonstrates Excellent Safety and Tolerability	Research Center for Biotechnology and Medicine Policy, RBMP
2025-12-13	Tanvex BioPharma Targets Year-End Revenue as Cipla Expands Market Share	MoneyDJ
2025-12-13	Chang Gung Memorial Hospital Completes 339 Fecal Microbiota Transplant Treatments, Launches “Gut Microbiome Whole-Genome Analysis” Technology	TechNews

■ Most Watched

■ Industry Watch

■ IBMI News

Information appearing on this website (images and texts, unless otherwise indicated) is the property of IBMI. To use or share, please indicate the source.

Address：9F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City , Taiwan (R.O.C.) Contact Number：(02)2655-8168 Fax：(02)2655-7978